These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3030301)

  • 1. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
    Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
    Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
    J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of a human monoclonal antibody to HLA by human-human hybridoma technology. A preliminary report.
    Hulette CM; Effros RB; Dillard LC; Walford RL
    Am J Pathol; 1985 Oct; 121(1):10-4. PubMed ID: 2996358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
    Kozbor D; Lagarde AE; Roder JC
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6651-5. PubMed ID: 6292911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human-human hybridoma secreting anti-Pseudomonas aeruginosa exotoxin-A monoclonal antibody with highly potent neutralizing activity.
    Kuriyama M; Ichimori Y; Iwasa S; Tsukamoto K
    Cytotechnology; 1990 Jan; 3(1):31-7. PubMed ID: 1369271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of ouabain-resistant human fusion partners.
    Ramachandra RN; Berczi I; Rector ES; Sehon AH
    J Immunol Methods; 1991 Aug; 142(1):21-9. PubMed ID: 1655911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
    Chiorazzi N; Wasserman RL; Kunkel HG
    J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
    Yu X; McGraw PA; House FS; Crowe JE
    J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D; Tripputi P; Roder JC; Croce CM
    J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The WI-L2-729-HF2 human hybridoma system. Stable hybrids at high frequency.
    Heitzmann JG; Cohn M
    Mol Biol Med; 1983 Sep; 1(2):235-43. PubMed ID: 6334216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Generation and characteristics of hybridomas producing monoclonal antibodies to the surface antigen of hepatitis B virus].
    Kushch AA; Momot AM; Shumaĭ EP; Bukrinskaia AG; Anan'ev VA
    Vopr Virusol; 1987; 32(4):448-51. PubMed ID: 3318133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody.
    Wallace EF; Foung SK; Bradbury K; Pask SL; Grumet FC
    Hum Immunol; 1990 May; 28(1):65-9. PubMed ID: 2160447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
    Gustafsson B; Jondal M; Sundqvist VA
    Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extreme strategy for the production of hybridoma.
    Golestani R; Pourfathollah AA; Moazzeni SM
    Hybridoma (Larchmt); 2009 Apr; 28(2):139-44. PubMed ID: 19249989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
    Perkins S; Foung SK
    Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.